KEAP1 Peptide (AAP34728)

Product Specifications

Gene Aliases

INrf2, KIAA0132, KLHL19, MGC10630, MGC1114, MGC20887, MGC4407, MGC9454

Gene ID

9817

Accession Number

NP_987096

Target

This is a synthetic peptide designed for use in combination with anti-KEAP1 antibody (Catalog #: ARP34728_T100) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

Partner Proteins

BPTF, ETF1, FAM46A, MYO7A, NFE2L2, ARCN1, BBS1, BTRC, C10orf119, COPG, CUL3, ETF1, FAM123B, FAM129B, GABPA, GBAS, GET4, KIAA0564, MAD2L1, MAZ, MYO7A, NFE2L2, OSBPL10, PFAS, PGAM5, RBM45, SASS6, SLK, SQSTM1, TMEM160, TSC22D4, UBC, USP11, ZRANB1

Type

Blocking Peptide

Applications

IHC, WB

Assay Protocol

Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Reconstitution & Storage Instructions Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Antibody Array (AA) Protocol

Format

Lyophilized powder

Reconstitution

Add 100ul of sterile PBS. Final peptide concentration is 1 mg/ml in PBS. For longer periods of storage, store at -20C. Avoid repeat freeze-thaw cycles.